The administration of aerosolized medication is a basic therapy for patients with numerous respiratory tract diseases, including obstructive airway diseases (OADs), cystic fibrosis (CF), and infectious airway diseases. The management and care for patients requiring mechanical ventilation remains one of the greatest challenges for medical practitioners, both in intensive care units (ICUs) and pulmonology wards. Aerosol therapy is often necessary for patients receiving noninvasive ventilation (NIV), which may be stopped for the time of drug delivery and administered through a metered-dose inhaler or nebulizer in the traditional way. However, in most severe cases, this may result in rapid deterioration of the patient's clinical condition. Unfortunately, only limited number of original well-planned studies addressed this problem. Due to inconsistent information coming from small studies, there is a need for more precise data coming from large prospective real life studies on inhalation techniques in patients receiving NIV.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008820PMC
http://dx.doi.org/10.1155/2018/8959370DOI Listing

Publication Analysis

Top Keywords

inhalation techniques
8
techniques patients
8
mechanical ventilation
8
therapy patients
8
airway diseases
8
patients receiving
8
patients
5
patients respiratory
4
respiratory failure
4
failure treated
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!